Industry Reports

Rigel Pharmaceuticals, Inc. (RIGL) - Financial and Strategic SWOT Analysis Review

Tuesday, Nov 15, 2016

Rigel Pharmaceuticals Inc (Rigel or 'the company') is a clinical-stage drug development company engaged in the discovery and development of novel, targeted drugs in the therapeutic areas of immunology, oncology and immuno-oncology. The company operates in the US, where it is headquartered in South San Francisco, California. It employed 126 people as of December 31, 2015. This comprehensive SWOT profile of Rigel Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile will help you formulate strategies that augment your business by enabling you understand your partners, customers and competitors better.

Read More>